AU598307B2 - Heterocyclic derivatives - Google Patents

Heterocyclic derivatives Download PDF

Info

Publication number
AU598307B2
AU598307B2 AU79871/87A AU7987187A AU598307B2 AU 598307 B2 AU598307 B2 AU 598307B2 AU 79871/87 A AU79871/87 A AU 79871/87A AU 7987187 A AU7987187 A AU 7987187A AU 598307 B2 AU598307 B2 AU 598307B2
Authority
AU
Australia
Prior art keywords
compound
acid
glutamyl
gamma
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU79871/87A
Other languages
English (en)
Other versions
AU7987187A (en
Inventor
James Leroy Kelley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU7987187A publication Critical patent/AU7987187A/en
Application granted granted Critical
Publication of AU598307B2 publication Critical patent/AU598307B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
AU79871/87A 1986-10-18 1987-10-16 Heterocyclic derivatives Ceased AU598307B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8625019 1986-10-18
GB868625019A GB8625019D0 (en) 1986-10-18 1986-10-18 Compounds

Publications (2)

Publication Number Publication Date
AU7987187A AU7987187A (en) 1988-04-21
AU598307B2 true AU598307B2 (en) 1990-06-21

Family

ID=10605978

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79871/87A Ceased AU598307B2 (en) 1986-10-18 1987-10-16 Heterocyclic derivatives

Country Status (11)

Country Link
US (1) US4880812A (enExample)
EP (1) EP0268377B1 (enExample)
JP (1) JPS63126868A (enExample)
AT (1) ATE73780T1 (enExample)
AU (1) AU598307B2 (enExample)
CA (1) CA1300807C (enExample)
DE (1) DE3777544D1 (enExample)
ES (1) ES2030735T3 (enExample)
GB (1) GB8625019D0 (enExample)
GR (1) GR3004273T3 (enExample)
ZA (1) ZA877801B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
JP2570670B2 (ja) * 1987-12-28 1997-01-08 味の素株式会社 トキソプラズマ増殖抑制剤
EP0341837A3 (en) * 1988-04-15 1990-08-16 The Wellcome Foundation Limited Glutamic acid derivatives
US4940713A (en) * 1988-04-15 1990-07-10 Burroughs Wellcome Co. Substituted glutamic acids
US5019577A (en) * 1988-04-15 1991-05-28 Burroughs Welcome Co. Novel compounds and use
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US4921836A (en) * 1989-05-17 1990-05-01 Burroughs Wellcome Co. Substituted glutamic acids
WO1990014340A1 (en) * 1989-05-17 1990-11-29 The Wellcome Foundation Limited Glutamic acid derivatives
US4971973A (en) * 1989-05-17 1990-11-20 Burroughs Wellcome Co. Glutamic acid derivatives
JP2983254B2 (ja) * 1989-06-14 1999-11-29 武田薬品工業株式会社 ピロロ〔２，３―ｄ〕ピリミジン誘導体の製造法およびその中間体
US5013738A (en) * 1990-04-18 1991-05-07 The Trustees Of Princeton University L-glutamic acid derivatives
EP0492316A1 (en) * 1990-12-14 1992-07-01 Takeda Chemical Industries, Ltd. Condensed heterocyclic oligoglutamate derivatives, their production and pharmaceutical compositions containing them
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5739141A (en) * 1992-12-16 1998-04-14 Agouron Pharmaceuticals, Inc. Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
US5945427A (en) * 1995-06-07 1999-08-31 Agouron Pharmaceuticals, Inc. Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
US5594139A (en) * 1993-01-29 1997-01-14 Agouron Pharmaceuticals, Inc. Processes for preparing antiproliferative garft-inhibiting compounds
US5831100A (en) * 1995-06-07 1998-11-03 Agouron Pharmaceuticals, Inc. Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates
AU2001282520A1 (en) * 2000-08-29 2002-03-13 Takeda Chemical Industries Ltd. Grk inhibitor
US20040170705A1 (en) * 2001-03-08 2004-09-02 Dusan Miljkovic Compositions and methods for non-insulin glucose uptake
US20040043959A1 (en) * 2002-03-04 2004-03-04 Bloom Laura A. Combination therapies for treating methylthioadenosine phosphorylase deficient cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592182B2 (en) * 1986-06-06 1990-01-04 Trustees Of Princeton University, The Diastereoisomeric tetrahydropyrido (2,3-d) pyrimidine derivatives
AU594163B2 (en) * 1986-06-30 1990-03-01 Trustees Of Princeton University, The 4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592182B2 (en) * 1986-06-06 1990-01-04 Trustees Of Princeton University, The Diastereoisomeric tetrahydropyrido (2,3-d) pyrimidine derivatives
AU594163B2 (en) * 1986-06-30 1990-03-01 Trustees Of Princeton University, The 4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivatives

Also Published As

Publication number Publication date
ES2030735T3 (es) 1992-11-16
CA1300807C (en) 1992-05-12
AU7987187A (en) 1988-04-21
EP0268377A3 (en) 1988-12-28
DE3777544D1 (de) 1992-04-23
US4880812A (en) 1989-11-14
ZA877801B (en) 1989-05-30
JPS63126868A (ja) 1988-05-30
EP0268377A2 (en) 1988-05-25
GR3004273T3 (enExample) 1993-03-31
EP0268377B1 (en) 1992-03-18
GB8625019D0 (en) 1986-11-19
ATE73780T1 (de) 1992-04-15

Similar Documents

Publication Publication Date Title
EP0268377B1 (en) Glutamic acid derivatives, processes and intermediates for their preparation and pharmaceutical formulations containing them
EP0031237B1 (en) Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
US4996207A (en) Three new non-polyglutamatable deazaaminopterins
DE3689250T2 (de) Pyrido-(-2,3-d-)-pyrimidinabkömmlinge.
US5354751A (en) Heteroaroyl 10-deazaamino-pterine compounds and use for rheumatoid arthritis
US6576637B1 (en) β-alanine derivatives
EP0077460B1 (en) Purine compounds endowed with immunomodulating activity
Hong et al. Synthesis and biological activity of analogs of naturally occurring 6-ureidopurines and their nucleosides
US5167963A (en) 8,10-dideazatetrahydrofolic acid derivatives
US4746659A (en) Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
JP2970698B2 (ja) 新生物病の処置用のジフルオログルタミン酸とフォ−レ−ト類及びアンチフォ−レ−ト類とのコンジュゲ−ト類
AU592182B2 (en) Diastereoisomeric tetrahydropyrido (2,3-d) pyrimidine derivatives
US5073554A (en) Two non-polyglutamatable antifolates
US2500296A (en) Synthesis of substituted pteridines
Sathe et al. Screening of in vitro anti-inflammatory activity of some newly synthesized fluorinated benzothiazolo imidazole compounds
CA2133442A1 (en) Deazaaminopterins for treatment of inflammation
US5281717A (en) Epoxysuccinamic acid derivatives
US5140044A (en) Ucn-1028d derivatives
Bisset et al. The Synthesis and Thymidylate Synthase Inhibitory Activity of L-. gamma.-L-Linked Dipeptide and L-. gamma.-Amide Analogs of 2-Desamino-2-methyl-N10-propargyl-5, 8-dideazafolic acid (ICI 198583)
DE60015931T2 (de) Verfahren zur herstellung eines chiralen-beta-aminosäureesters
US4940713A (en) Substituted glutamic acids
Heinisch et al. Diazine‐substituted tert‐butylureas and tert‐butylthioureas and a convenient access to the related carbodiimides
Jonak et al. Effect of the substituent at C-6 on the biological activity of 2, 4-diamino-5-(1-adamantyl) pyrimidines
ES2308749T3 (es) Derivados de pirimidina condensada como inhibidores de enzimas dependientes de acido folico.
Roberts et al. Folic acid analogs. Modifications in the benzene-ring region. 4. 3'-Ethyl-and 3'-isopropylfolic acids